Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 062723
Company: ABRAXIS PHARM
Company: ABRAXIS PHARM
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
CEPHAPIRIN SODIUM | CEPHAPIRIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE;INJECTION | Discontinued | None | No | No |
CEPHAPIRIN SODIUM | CEPHAPIRIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE;INJECTION | Discontinued | None | No | No |
CEPHAPIRIN SODIUM | CEPHAPIRIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE;INJECTION | Discontinued | None | No | No |
CEPHAPIRIN SODIUM | CEPHAPIRIN SODIUM | EQ 4GM BASE/VIAL | INJECTABLE;INJECTION | Discontinued | None | No | No |
CEPHAPIRIN SODIUM | CEPHAPIRIN SODIUM | EQ 20GM BASE/VIAL | INJECTABLE;INJECTION | Discontinued | None | No | No |